Taylor, P. N., Collins, K. S., Lam, A., Karpen, S. R., Greeno, B., Walker, F., . . . Dayan, C. M. (2023). C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: An individual participant meta-analysis. The lancet. Diabetes & endocrinology, 11(12), 915. https://doi.org/10.1016/S2213-8587(23)00267-X
Chicago Style (17th ed.) CitationTaylor, Peter N., et al. "C-peptide and Metabolic Outcomes in Trials of Disease Modifying Therapy in New-onset Type 1 Diabetes: An Individual Participant Meta-analysis." The Lancet. Diabetes & Endocrinology 11, no. 12 (2023): 915. https://doi.org/10.1016/S2213-8587(23)00267-X.
MLA (9th ed.) CitationTaylor, Peter N., et al. "C-peptide and Metabolic Outcomes in Trials of Disease Modifying Therapy in New-onset Type 1 Diabetes: An Individual Participant Meta-analysis." The Lancet. Diabetes & Endocrinology, vol. 11, no. 12, 2023, p. 915, https://doi.org/10.1016/S2213-8587(23)00267-X.